The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy
-
* Corresponding author: Frank Speleman franki.speleman@ugent.be
Genome Med 2009, 1:74 doi:10.1186/gm74
Accesses
- Last 30 days: 93 accesses
- Last 365 days: 928 accesses
- All time: 2448 accesses
Cited by
BioMed Central: 1 citation
|
Candy Kumps, Nadine Van Roy, Lien Heyrman, Dirk Goossens, Jurgen Del-Favero, Rosa Noguera, Jo Vandesompele, Frank Speleman, Katleen De Preter BMC Genomics 2010, 11:298 (12 May 2010) |